DEA decision keeps major restrictions in place on marijuana research
Federal drug enforcement authorities will continue defining marijuana as a drug with a high potential for abuse and no accepted medical value, a decision that keeps in place significant restrictions on biomedical research. The decision by the Drug Enforcement Administration, reported by news outlets late Wednesday, means marijuana will remain classified as a Schedule 1 drug.…
.rhexcerpt{display:none;}